Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
i
4h
Alzheimer’s ‘wonder drug’ was recommended by scientists funded by pharma firms
A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...
17h
Jim Cramer Reports That Eli Lilly and Company (LLY)’s Donanemab Was Approved in Japan For Treating Early Symptomatic Alzheimer’s Disease
Stocks to Watch. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
Rescue mission launched
NC dam failure ‘imminent’
Houthis attack US warships
Congestion fee bid denied
Troops to leave some bases
High-end brothel plea
Hospitalized for burns
'SNL' launches 50th season
Human rabies death in MN
AL sued over purging voters
ICE: Convicts roaming free
Van Gogh paintings attacked
UNC digital IDs blocked
Congressional Gold Medal
KY sues Express Scripts
Vance’s Pennsylvania rally
Hezbollah leader killed
Malibu coast earthquake
Fed inflation gauge cools
CA stove labels bill vetoed
Dow closes at record high
NY ballot appeal rejected
Haney sues Garcia
Meta hit with privacy fine
121st loss of the season
On Hezbollah leader's killing
Diocese reaches settlement
Deposition in AI suit
Faces fine to end Brazil ban
Related topics
Eli Lilly
Alzheimer
Japan
Food and Drug Administration
Kisunla
Feedback